UNICREDIT BANK/CALL/MODERNA/80/0.1/18.09.24 Stock

Warrant

UD0DQK

DE000HD0DQK6

Market Closed - Borsa Italiana 04:04:59 2024-07-08 pm EDT
3.54 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/MODERNA/80/0.1/18.09.24
Current month-6.84%
1 month-47.63%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-08 3.54 -4.58%
24-07-05 3.71 -2.11%
24-07-04 3.79 +7.06%
24-07-03 3.54 -2.75%
24-07-02 3.64 +2.25%

Real-time Borsa Italiana

Last update July 08, 2024 at 04:04 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MODERNA, INC.
IssuerLogo Issuer UniCredit UniCredit
UD0DQK
ISINDE000HD0DQK6
Date issued 2023-11-01
Strike 80 $
Maturity 2024-09-18 (72 Days)
Parity 10 : 1
Emission price-
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.37
Lowest since issue 1.025
Spread 0.01
Spread %0.28%

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
116.4 USD
Average target price
145.9 USD
Spread / Average Target
+25.25%
Consensus
  1. Stock Market
  2. Warrants
  3. UD0DQK Warrant